Haiping Wang

16 Jiangsu Road
Qingdao, 266000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic Peptide Enhances Neurovascular Regeneration in Ischemic Stroke.

Functional ECM Hydrogel for Targeted Delivery of bFGF and Angiopoietin-1 Mimetic Peptide Enhances Neurovascular Regeneration in Ischemic Stroke.

Journal: ACS applied bio materials

Published: May 07, 2026

Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority.

Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority.

Journal: Frontiers in nephrology

Published: September 29, 2025

Factors influencing postoperative hyperbilirubinemia in valvular heart disease and establishment of a predictive model.

Factors influencing postoperative hyperbilirubinemia in valvular heart disease and establishment of a predictive model.

Journal: Frontiers in cardiovascular medicine

Published: April 14, 2025

The Combined Use of Levodopa/Benserazide and Pramipexole Proves Beneficial for Managing Parkinson's Disease.

The Combined Use of Levodopa/Benserazide and Pramipexole Proves Beneficial for Managing Parkinson's Disease.

Journal: Actas espanolas de psiquiatria

Published: December 12, 2024

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.

Journal: Frontiers in pharmacology

Published: November 25, 2024

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling.

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling.

Journal: Frontiers in pharmacology

Published: November 22, 2024

Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy.

Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy.

Journal: Clinical kidney journal

Published: November 06, 2024

Value of preoperative prognostic nutritional index combined with NT-proBNP in predicting acute kidney injury of congenital heart disease children.

Value of preoperative prognostic nutritional index combined with NT-proBNP in predicting acute kidney injury of congenital heart disease children.

Journal: PeerJ

Published: June 18, 2024

Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia.

Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia.

Journal: Frontiers in pharmacology

Published: December 01, 2023

A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury.

A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury.

Journal: Neural regeneration research

Published: August 08, 2023

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.

Journal: Frontiers in pharmacology

Published: February 10, 2023

Altered large-scale internetwork functional connectivity in patients with vestibular migraine and migraine without aura.

Altered large-scale internetwork functional connectivity in patients with vestibular migraine and migraine without aura.

Journal: Neuroscience letters

Published: October 23, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026